Pear Therapeutics, Inc.
Pear Therapeutics, Inc., a pioneering leader in the digital therapeutics industry, is headquartered in the United States. Founded in 2013, the company has made significant strides in developing prescription digital therapeutics designed to treat various mental health and substance use disorders. With a focus on evidence-based solutions, Pear Therapeutics offers unique products such as reSET and reSET-O, which integrate seamlessly with traditional therapies to enhance patient outcomes. These innovative offerings set the company apart in a rapidly evolving market, positioning it as a key player in the intersection of technology and healthcare. Recognised for its commitment to advancing therapeutic options, Pear Therapeutics continues to shape the future of treatment through its cutting-edge digital solutions, addressing critical needs in patient care.
DitchCarbon Score
How does Pear Therapeutics, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Computer Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Pear Therapeutics, Inc.'s score of 23 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Pear Therapeutics, Inc.'s reported carbon emissions
Pear Therapeutics, Inc., headquartered in the US, currently does not have publicly available carbon emissions data for the most recent year, nor does it report any specific reduction targets or initiatives. The company has not disclosed any commitments to the Science Based Targets initiative (SBTi) or other climate pledges. As such, there are no emissions figures, such as Scope 1, 2, or 3 emissions, to report. In the absence of specific emissions data or reduction initiatives, it is unclear how Pear Therapeutics is addressing climate change or its carbon footprint. The lack of information may reflect a broader trend in the industry where companies are still developing their sustainability strategies.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Pear Therapeutics, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
